Clinical Trial Update: Allogeneic Bone Marrow Mesenchymal Stem Cells Transplantation in Patients With Liver Failure Caused by Hepatitis B Virus (HBV) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic bone marrow mesenchymal stem cell transplantation for liver failure caused by hepatitis B virus. The current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Failure

Drugs mentioned

• Allogeneic bone marrow mesenchymal stem cells (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Liver Failure | Phase 2 | Status: UNKNOWN